Inflammatory bowel disease (IBD) is characterized by the high level of reactive oxygen
species (ROS) and highly dysfunctional intestinal flora. Here, a stimulation-responsive …

The malignancy of colorectal cancer (CRC) is connected with inflammation and tumor-
associated macrophages (TAMs), but effective therapeutics for CRC are limited. To integrate …

The degree of tissue injuries such as the level of scarring or organ dysfunction, and the
immune response against them primarily determine the outcome and speed of healing …

The complex pathogenesis of inflammatory bowel disease (IBD) explains the several
hurdles for finding an efficient approach to cure it. Nowadays, therapeutic protocols aim to …

Aberrant M1/M2 macrophage polarization and dysbiosis are involved in the pathogenesis of
ulcerative colitis (UC). Ginsenoside Rg1 exhibits optimal immunomodulatory and anti …

Non‐invasive localization of lesions and specific targeted therapy are still the main
challenges for inflammatory bowel disease (IBD). Ta, as a medical metal element, has been …

Herein, dual-bioresponsive of Rhein (RH) in promoting colonic mucous damage repair and
controlling inflammatory reactions were combined by the dual-targeting (intestinal epithelial …

Oral drug delivery is a common route for management of inflammatory bowel disease (IBD)
but suffers from low bioavailability and systemic side effects during passage through the …

Despite immunosuppression is critical for reducing immune overactivation, existing
immunosuppressive agents are largely restricted by low inhibition efficiencies and …

The occurrence and development of inflammatory bowel diseases (IBDs) are inextricably
linked to the excessive production of reactive oxygen species (ROS). Thus, there is an …